Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tamoxifen to Reduce Unscheduled Bleeding in New Users of the Levonorgestrel-releasing Intrauterine System (LNG-IUS)

NCT02824224 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.

NCT NCT02824224
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02824224 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tamoxifen to Reduce Unscheduled Bleeding in New Users of the Levonorgestrel-releasing Intrauterine System (LNG-IUS)
Lead sponsor
Oregon Health and Science University
Phase
Phase 4
Overall status
Completed
Start date
September 6, 2016
Completion date
January 8, 2018
Enrollment
42 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

medicated intrauterine devices, menorrhagia, metrorrhagia